Sunshine Nuohe officially signed a contract with Huawei Cloud to jointly build a new ecosystem for AI peptide drug research and development.

Recently, Beijing Sunflower Nuohuo Pharmaceutical Research Co., Ltd., a wholly-owned subsidiary of Guangdong Nuohuo Smart Peptide Biotechnology Co., Ltd., signed a formal agreement with Huawei Cloud Computing Technology Co., Ltd. The two parties will jointly build a "peptide molecular large model platform" based on Huawei Cloud Pangaea Large Model Technology. This cooperation marks a crucial step for Sunflower Nuohuo in AI-empowered peptide new drug research and development, accelerating the transition from "following innovation" to "global leadership".